Botulinum toxin type A (BTXA) is effective in the treatment of keloids and other hypertrophic scarring, but the mechanism has not always been clear. The hypothesis behind the early use of BTXA to treat these conditions was that BTXA may inhibit the growth of fibroblasts. A recent study further explored that mechanism by examining the …
Excessive sweating (hyperhidrosis) occurs in up to 3% of the population and can be seen all over the body or localized to the axilla, palms or feet (Primary focal hyperhidrosis, PFH). However, the condition can also be seen in the face or scalp area (craniofacial hyperhidrosis). A recent study sought to characterize this issue in …